Alpha-1 MP (Alpha-1 Proteinase Inhibitor, Human, Modified Process)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Alpha-1 MP (Alpha-1 Proteinase Inhibitor, Human, Modified Process), covering 2026-03-04 to 2026-03-04. Get the full timeline:
Most recent: Clinical Trial Update: Efficacy and Safety of Alpha1-Proteinase Inhibitor (Human), Modified Process (Alpha-1 MP) in Subjects With Pulmonary Emphysema Due to Alpha1 Antitrypsin Deficiency (AATD) [Phase 3]